Annual General Meeting of Gerresheimer AG decides to pay dividend

Date: 18 April 2011

Düsseldorf, April 14, 2011 – At its Annual General Meeting today Gerresheimer AG looked back at the very good financial year 2010.

The shareholders passed a resolution approving payment of a dividend of EUR 0.50 per share.

At the meeting of shareholders in Düsseldorf the CEO Uwe Röhrhoff summarized the year as follows: “The financial year 2010 went very successfully for us. Our products and services are very popular with our international pharma customers. We achieved our targets and actually exceeded some of them. We wish to allow our shareholders to participate in this success.”

“In the coming years we see further major growth opportunities, particularly in the emerging countries. We want to become the leading global partner for solutions which contribute to improvements in health and well-being,” Röhrhoff added.

The dividend of EUR 0.50 per share is to be paid on April 15, 2011. The dividend distribution is basically tax-free for shareholders based in Germany. No dividend was paid in the prior year.

With capital stock representation of 68.27 percent the General Meeting passed the following resolutions on agenda items:

ITEM 2: Appropriation of net earnings for the financial year 2010: Votes in favor 99.99 percent

ITEM 3: Formal approval of the actions of the members of the Management Board for the financial year 2010: Votes in favor 96.34 percent

ITEM 4: Formal approval of the actions of the members of the Supervisory Board for the financial year 2010: Votes in favor 98.52 percent

ITEM 5: Election of the auditor for the financial year 2011: Votes in favor 99.69 percent

The speech to the General Meeting can be found under www.gerresheimer.com/investor-relations/hauptversammlung About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion Euros and has 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

600450 Annual General Meeting of Gerresheimer AG decides to pay dividend glassonweb.com

See more news about:

Others also read

Proprietary laminate windows collect, store energy; convert it to electricityRIVIERA BEACH, FL – An innovative new patented technology transforms office building windows into "solar farms" and allows these structures to reuse collected energy and become self-sufficient in the event of a power outage.
DALLAS, Texas, December 22, 2011 /PRNewswire/ --ReportsnReports adds new market research report 'Solar Photovoltaic (PV) Power - Global Market Size, Installation Prices, Module Market Shares, Market Segmentation, Regulations and Key Country Analysis to 2020' to its store.
The University of Minnesota's historic Folwell Hall completed three years of extensive renovation, just time for the 2011 academic year.
The renewal process for AAMA Corporate Members is now open. AAMA Corporate Membership is available to businesses involved in the manufacture, sale or service of fenestration products and is renewed on an annual basis.
Today designers and architects are looking to the hotel bathroom as the new frontier of the guestroom, turning what has long been a mostly functional space into a haven and means of escape.
Glassman as one of the largest glass processing machine manufactures in the world presented ZAK Glass Technology Exhibition during 8-11 December 2011, in Mumbai, India.

Add new comment